Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials

Susan J. Tofte^*, Kim Papp, Neil Sadick, Krista Bohnert, Eric Simpson, Diamant Thaçi, Thomas Bieber, Andrew Blauvelt, Howard Sofen, Melinda Gooderham, Zhen Chen, Abhijit Gadkari, Laurent Eckert, Neil M.H. Graham, Gianluca Pirozzi, Marius Ardeleanu